InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,738.17
(
-0.13%
)
US TECH 100
19,436.00
(
-0.73%
)
Dow Jones
42,313.00
(
0.33%
)
Brent Oil
72.01
(
0.00%
)
Bitcoin
65,942.78
(
0.10%
)
Post# of 132
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

manny21

Send PM Follow Ignore
Followers 0
Posts 51
Boards Moderated 0
Alias Born 05/02/2006

manny21

Re: None

Monday, 10/23/2006 10:54:08 AM

Monday, October 23, 2006 10:54:08 AM

Post# of 132
Dear Manny,

The product PHER-O2 is in its pre IND phase with Cardinal Health and the
University of Alberta. The company has heard from the FDA and the FDA has
determined that the trial approach is as a device, which I understand from
Cardinal is a very good thing.

Best regards
Michael Dancy

invest at your own risk, based on your own due diligence, at your own risk tolerance

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up